Walk a Kb or Two in my Moccasins- Nobody 'splained it to me like that!: 20 December 2021

Walk a Kb or Two in my Moccasins- Nobody 'splained it to me like that!

Simple answers to Complex Questions and Complex Answers to Simple Questions. In real life, I'm a Greater-Toronto (Canada) Realtor with RE/MAX Hallmark Realty Ltd, Brokerage. I first joined RE/MAX in 1983 and was first Registered to Trade in Real Estate in Ontario in 1974. Formerly known as "Two-Finger Ramblings of a Forensic Acuitant turned Community Synthesizer"

Monday, December 20, 2021

Pfizer’s Own Stats: 1200+/40,000 Trial Participants Dead | Interview with Dr. Nagase

Dr. Daniel Nagase graduated from Dalhousie Medical School in 2004, is a registered member of the College of Physicians and Surgeons in Alberta where he has been a doctor for over 15 years, an emergency doctor for 10 years and has treated patients in rural under-serviced communities throughout Alberta since 2015. Dr. Nagase was fired after treating three Covid patients with Ivermectin at the Rimbey Hospital and Care Centre. Listen to him speak on the dangers of the injection from a microbiology perspective.

Pfizer’s COVID vaccine trial results; are these statistics “acceptable”?

Absolutely not. They wouldn’t be acceptable for any medication brought to market, this magnitude of side effects, 31% either died, had permanent disability or were not recovered. It’s insane that at the time of the report to government authorities, April 30th, 2021 that this drug, this injection wasn’t pulled off the market immediately.

Explaining some devastating known side effects…

watch the whole interview

https://strongandfreecanada.org/vlog/breaking-news-pfizers-own-stats-1200-40000-trial-participants-dead-interview-with-dr-nagase/

Vinay Prasad MD MPH intro'd me to this on Youtube

https://youtu.be/xzVoS-1TIWI

He suggests this link to paper

He wrote an article in June 2021 CDC's All-or-Nothing Approach to Teen COVID Vaccination Is All Wrong

Regarding the Ontario Results -- PICK ONE you like - several from Ontario Public Health

Myocarditis and Pericarditis Following Vaccination with ...

https://www.publichealthontario.ca › - › media › documents › ncov › epi › covid-19-myocarditis-pericarditis-vaccines-epi.pdf?sc_lang=en

Myocarditis/pericarditis following COVID-19 mRNA vaccines remains a rare AEFI (defined by the Canadian Immunization Guide as occurring at frequency of 0.01% to less than 0.1%), even among the age groups where the highest rates of this event have been observed. 7

Epidemiology of myocarditis and pericarditis following ...

https://www.medrxiv.org › content › 10.1101 › 2021.12.02.21267156v1

Results: There were 19,740,741 doses of mRNA vaccines administered and 297 reports of myocarditis/pericarditis meeting our inclusion criteria. Among these, 69.7% occurred following the second dose of COVID-19 mRNA vaccine and 76.8% occurred in males. The median age of individuals with a reported event was 24 years.

PDF Myocarditis and Pericarditis Following COVID-19 mRNA Vaccines

https://www.publichealthontario.ca › - › media › documents › ncov › vaccines › 2021 › 06 › covid-19-mrna-vaccines-myocarditis-pericarditis.pdf?la=en&_cldee=cXVlZW52aWV3QG91dGxvb2suY29t&recipientid=contact-f6a097b2b771e411a5800050569e0009-62cd4a890efb41dd9f2f8f7a91d00937&esid=0f693720-ffd4-eb11-9ebb-0050569e118f

Myocarditis and pericarditis following COVID-19 mRNA vaccines 1 AT A GLANCE Myocarditis and Pericarditis Following COVID-19 mRNA Vaccines 2nd revision - October 1, 2021 Background In May 2021, international reports of myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the lining around the heart) following vaccination with COVID-19 mRNA vaccines emerged ...

PDF Myocarditis and Pericarditis after COVID-19 mRNA Vaccines

https://www.publichealthontario.ca › - › media › documents › ncov › vaccines › 2021 › 11 › myocarditis-pericarditis-mrna-vaccines.pdf?sc_lang=en

Epidemiology of Myocarditis/Pericarditis after COVID-19 Vaccination Reporting Rate of Myocarditis/Pericarditis in the United States As of June 30, 2021, reporting rate of myocarditis overall among adults was 3.5 cases per million second doses of mRNA COVID-19 vaccine (Pfizer-BioNTech or Moderna) administered based on

Epidemiology of myocarditis and pericarditis following ...

https://www.researchgate.net › publication › 356792259_Epidemiology_of_myocarditis_and_pericarditis_following_mRNA_vaccines_in_Ontario_Canada_by_vaccine_product_schedule_and_interval

Results: There were 19,740,741 doses of mRNA vaccines administered and 297 reports of myocarditis/pericarditis meeting our inclusion criteria. Among these, 69.7% occurred following the second dose...

Reports of myocarditis and pericarditis after ... - canada.ca

https://www.canada.ca › en › public-health › services › diseases › 2019-novel-coronavirus-infection › guidance-documents › reports-myocarditis-pericarditis-after-vaccination-communique-health-practitioners-june-3-2021.html

In May 2021, international reports of myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the lining around the heart) following vaccination with COVID-19 mRNA vaccines emerged, including from Israel and the United States. Available information indicates that: Cases were more commonly reported after the second dose

Epidemiology of myocarditis and pericarditis following ...

https://canadianmale.wordpress.com › 2021 › 12 › 11 › epidemiology-of-myocarditis-and-pericarditis-following-mrna-vaccines-in-ontario-canada-by-vaccine-product-schedule-and-interval

Results There were 19,740,741 doses of mRNA vaccines administered and 297 reports of myocarditis/pericarditis meeting our inclusion criteria. Among these, 69.7% occurred following the second dose of COVID-19 mRNA vaccine and 76.8% occurred in males. The median age of individuals with a reported event was 24 years.

Recommendation on the use of mRNA COVID-19 vaccines in ...

https://www.canada.ca › en › public-health › services › immunization › national-advisory-committee-on-immunization-naci › rapid-response-recommendation-use-covid-19-vaccines-individuals-aged-12-years-older-myocarditis-pericarditis-reported-following-mrna-vaccines.html

post-market safety surveillance on mrna covid-19 vaccines identified that when myocarditis and/or pericarditis occurs, it occurs usually within a week following vaccination, most frequently in adolescents and young adults (12 to 29 years of age), more frequently in males compared to females, and more frequently after the second dose as compared …

Myocarditis Risk from the Vaccine vs. Virus: the UK Study

Study 1. "Epidemiology of myocarditis and pericarditis following mRNA vaccines in Ontario, Canada: by vaccine product, schedule and interval" (medrxiv.org) Population: Ontario, Canada (14.7 million) who received at least one dose of COVID-19 mRNA vaccine between December 14, 2020 and September 4, 2021.